Low-Cost, Pharmaceutical-Grade Cannabis for Global Markets
CannabCo Pharmaceutical Corp. is a Canadian-based full-service cannabis company with operations in Brampton, Ontario. The company has received its confirmation of readiness status from Health Canada to become a licensed producer and is currently building out its pilot facility in the Brampton area.
The company is dedicated to establishing itself as a leader in top quality affordable pharmaceutical grade Cannabis supply and cutting-edge research contributing to the growing needs of the Cannabis industry.
CannabCo will employ the most advanced cultivation, processing and packaging technologies with a focus on quality at reduced costs using Pharmaceutical methodology within a GMP environment.
CannabCo intends to use an enhanced technology known as PHOENIX for its cultivation initiatives, achieving high productivity and significantly lower cost at under $.50 per gram. The company intends to launch extraction initiatives as well as enter the oils, extracts and consumable markets upon completion of its 17,500-square-foot pilot facility. The facility is being built to EU GMP standards allowing access to the underserviced global pharmaceutical market.